SIGNALS BIODESIGN Trademark

Trademark Overview

On Monday, June 24, 2024, a trademark application was filed for SIGNALS BIODESIGN with the United States Patent and Trademark Office. The USPTO has given the SIGNALS BIODESIGN trademark a serial number of 98614737. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Thursday, February 5, 2026. This trademark is owned by Revvity Signals Software, Inc.. The SIGNALS BIODESIGN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Compiling data for research purposes in the field of medical science and medical consultancy; Software as a service (SAAS) services featuring software for use in molecular biology for providing workflows to design molecular constructs; Software as a service (SAAS) services featuring software for use in genetic engineering to enable codon optimization, reverse translation, and cloning to alter nucleic acid and protein sequences; Software as a service (SAAS) services featuring software for scientific research for performing sequence alignments; Software as a service (SAAS) services featuring software for use in biotechnology research for providing annotatable sequence libraries
signals biodesign

General Information

Serial Number98614737
Word MarkSIGNALS BIODESIGN
Filing DateMonday, June 24, 2024
Status760 - EX PARTE APPEAL PENDING
Status DateThursday, February 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCompiling data for research purposes in the field of medical science and medical consultancy; Software as a service (SAAS) services featuring software for use in molecular biology for providing workflows to design molecular constructs; Software as a service (SAAS) services featuring software for use in genetic engineering to enable codon optimization, reverse translation, and cloning to alter nucleic acid and protein sequences; Software as a service (SAAS) services featuring software for scientific research for performing sequence alignments; Software as a service (SAAS) services featuring software for use in biotechnology research for providing annotatable sequence libraries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRevvity Signals Software, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Monday, June 24, 2024NEW APPLICATION ENTERED
Thursday, December 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 14, 2025ASSIGNED TO EXAMINER
Thursday, January 16, 2025NON-FINAL ACTION WRITTEN
Thursday, January 16, 2025NON-FINAL ACTION E-MAILED
Thursday, January 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 7, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, April 7, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, July 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 11, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 5, 2025FINAL REFUSAL WRITTEN
Tuesday, August 5, 2025FINAL REFUSAL E-MAILED
Tuesday, August 5, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 23, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 23, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 5, 2026EXPARTE APPEAL RECEIVED AT TTAB
Thursday, February 5, 2026JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, February 5, 2026EX PARTE APPEAL-INSTITUTED
Thursday, February 5, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 11, 2026ASSIGNED TO LIE
Wednesday, February 11, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 11, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

biodesign signals software service featuring saas services research providing molecular sequence medical